首页>投融资
Delfi Diagnostics
股权融资
Delfi Diagnostics Inc detect cancer early, when it is most curable, using high precision non-invasive blood tests.In July 2022, Delfi Diagnostics Inc announced a Series B funding of $225 million led by DFJ Growth, Eli Lilly and Company, Point72, Brown Advisory, Point Field Partners, Initiate Ventures, Open Field Capital, PTX Capital
基本信息
-
公司全称Delfi Diagnostics Inc
-
类型液体活检测试产品开发商
-
产业领域医药研发/制造、化学&生物药、医疗器械
-
公司人数15~50人
-
地址1810 Embarcadero Road Suite 100 PALO ALTO CALIFORNIA 94303; US; Telephone: +18005892182;
-
联系电话800-589-2182
-
邮箱info@delfidiagnostics.com
-
成立时间2019-01-01
投融资
-
2024-06-04股权融资未透露Merck GHI Fund
-
2022-07-18B轮2.25亿美元DFJ GrowthWindham Venture PartnersOsage University PartnersIllumina VenturesAV8 VenturesRock Springs CapitalSamsara BioCapitalNorthpond VenturesT. Rowe Price奥博资本MenloForesite CapitalCowen Healthcare InvestmentsPTX CapitalOpen Field CapitalInitiate VenturesPoint Field PartnersBrown AdvisoryPoint 72Eli Lilly
-
2021-01-12A轮1亿美元Samsara BioCapitalWindham Venture PartnersAV8 Ventures奥博资本Illumina VenturesCowen Healthcare InvestmentsNorthpond VenturesT. Rowe PriceForesite CapitalRock Springs CapitalMenlo
相关投融资企业
上市后再融资
Delcath Systems, Inc.于1988年8月在特拉华州公司注册成立。该公司是一个后期临床开发公司,致力于研究肝脏癌症,是一家专业制药和医疗器械公司,开发专利产品 - 美法仑注射用盐酸,用于Delcath肝输送系统(美法仑/ HDS)的使用。
D轮
PrognomIQ, a spin-out of Seer, is a healthcare company focused on the development and commercialization of multi-omics human tests for cancer and other diseases.In September 2020, Seer Inc announced that it has spun out and completed the initial financing of $55M for a newly formed healthcare company, PrognomIQ, Inc..In September 2021, Seer, Inc announced that it has spun out and completed the initial financing of $55M for PrognomIQ, Inc
增发
GE HealthCare Technologies Inc.于2022年5月16日作为特拉华州有限责任公司成立。根据重组,该公司将成为一家控股公司,其资产预计将包括通用电气公司(“GE”)旗下业务GE 医疗保健的所有未偿还股权。GE 医疗保健是全球领先的医疗技术、药物诊断和数字解决方案创新者。他们的产品、解决方案和服务涵盖患者护理的连续过程,包括筛查、诊断、治疗和监测,目标是使临床医生能够以更低的成本提供更好的护理。他们在全球拥有超过400万台医疗设备的安装基础,每年可实现超过20亿次手术,影响超过10亿患者。他们的补充药物诊断剂以每秒大约三名患者的速度用于成像程序。